Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myelomonocytic, Chronic × entrectinib × 1 year × Clear all

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 6 Brain Neoplasms 3 Thyroid Cancer, Papillary 2 Sarcoma 2 Salivary Gland Neoplasms 2 Neoplasms 2 Neoplasm Metastasis 2 Glioma 2 Central Nervous System Neoplasms 2 Wilms Tumor 1 Solid Tumors 1 Sarcoma, Ewing 1 Recurrence 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neuroendocrine Tumors 1 Neuroblastoma 1 Nephroma, Mesoblastic 1 Neoplasms, Unknown Primary 1 Neoplasms by Site 1 Neoplasms by Histologic Type 1 Melanoma 1 Medulloblastoma 1 Lymphoproliferative Disorders 1 Lymphoma, Large-Cell, Anaplastic 1 Leukemia, Myeloid, Acute 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Colorectal Neoplasms 1 Cholangiocarcinoma 1

Interventions

Azacitidine 29 venetoclax 21 Cyclophosphamide 17 Whole-Body Irradiation 14 fludarabine phosphate 13 Biopsy 13 fludarabine 12 Tacrolimus 12 Specimen Handling 12 Mycophenolic Acid 11 Decitabine 11 Cytarabine 10 Stem Cell Transplantation 9 Peripheral Blood Stem Cell Transplantation 9 Injections 8 decitabine and cedazuridine drug combination 7 Melphalan 7 Busulfan 6 X-Rays 5 Hematopoietic Stem Cell Transplantation 5 Granulocyte Colony-Stimulating Factor 4 Filgrastim 4 Cyclosporine 4 sabatolimab 3 olutasidenib 3 enasidenib 3 cedazuridine 3 Sirolimus 3 Rituximab 3 Magnetic Resonance Spectroscopy 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡